A Tale of Two Realities

George Yacik - INO.com Contributor - Fed & Interest Rates


You may not have noticed it, but there is an enormous gulf between what many Americans are being told is happening in the world around us and how the financial markets are reacting – or, more accurately, not reacting – to it. It’s as if there are two completely different realities going on. Which reality you subscribe to will likely dictate your investment choices, including how you feel about which direction the bond market is headed.

In one reality – and it’s the one that gets the most coverage in the general media – is that the world is basically coming to an end. The most powerful nation on earth is being run for the past two weeks or so – although it seems like a lot longer – by an ignoramus who is moving our country and the entire world headlong into disaster. Continue reading "A Tale of Two Realities"

Canada's Only Legal Monopoly Is Up 360% In 12 Months

Analysis originally distributed on February 1, 2017 By: Michael Vodicka of Cannabis Stock Trades

If you want to invest in a legal monopoly – I’ve got just the cannabis stock for you.

This early industry leader is the only Canadian cannabis stock with a license to produce and sell cannabis in Alberta – Canada’s fast-growing and fourth-largest province with a population of 4.1 million.

It just reported record first-quarter results, with revenue up 151% from just last quarter.

And finally, it’s in the early stages of building an 800,000 square foot, state of the art, cultivation center.

When you add it all together, this early industry leader is one of the most exciting stocks in the cannabis sector.

Aurora Cannabis Inc. (NASDAQ:ACBFF) is the second largest medical cannabis company in Canada with a market cap of $650 million.

Aurora currently operates a 55,200 square foot cultivation facility in Mountain View County. Continue reading "Canada's Only Legal Monopoly Is Up 360% In 12 Months"

Unexpected Fall Of Gasoline Inventory Pushes Oil Higher

Hello MarketClub members everywhere. Oil prices rose off the morning lows after government data showed that U.S. gasoline supplies unexpectedly slipped, while crude stockpiles have increased the most since October.

Gasoline stockpiles fell 869,000 barrels, pushing refining margins higher. Crude inventories climbed 13.8 million barrels in the week ended Feb. 3, the Energy Information Administration (EIA) said. That was in line with the industry-funded American Petroleum Institute, which reported a 14.2 million-barrel increase on Tuesday. Gasoline demand climbed the most in a year.

MarketClub's Mid-day Market Report

"There's been a lot of concern about plunging gasoline demand and with this report, it's returned to normal levels," John Kilduff, a partner at Again Capital LLC, a New York-based hedge fund that focuses on energy, said by telephone. "Healthy gasoline demand eventually translates into higher refinery runs and increasing crude demand." Continue reading "Unexpected Fall Of Gasoline Inventory Pushes Oil Higher"

Preview Issue #10: Trump Fires Shot, Valeant Divesture and Generic EpiPen Launches

INO Health & Biotech Stock Guide

Preview Issue #10 - February 8, 2017

BIOTECH, HEALTH & PHARMA NEWS

Prior to his inauguration, president-elect Trump held a press conference and chimed in on his stance with regard to the pharmaceutical industry and more specifically drug pricing. Trump stated that drug companies are "getting away with murder" when speaking to the drug pricing issue that has taken center stage throughput the presidential campaign. These remarks immediately resulted in a broad sell-off across the entire biotech cohort. The iShares Nasdaq Biotechnology ETF (IBB) shed more than 2.5% or $7 per share as these comments were heard during the live broadcast. Although the political uncertainty has abated, Donald Trump has been able to single handily influence the movement of specific stocks (i.e. Lockheed Martin, Ford, Boeing, etc.) and sectors (i.e. automotive, biotechnology and healthcare). The overall healthcare umbrella has become volatile on the heels of any statement or tweet from Donald Trump and thus one can expect continued volatility until the crosshairs are directed elsewhere.

WHAT'S NEXT

Continue reading "Preview Issue #10: Trump Fires Shot, Valeant Divesture and Generic EpiPen Launches"

Copper's Consolidation Offers Buying Opportunity for Freeport-McMoRan

Aibek Burabayev - INO.com Contributor - Metals


Every great party is followed by a hangover; every good rally is followed by a consolidation.

Chart 1. Copper Weekly: Consolidation

Weekly Copper Chart
Chart courtesy of tradingview.com

Copper was a hit at the end of last year. The price has gained more than 30% at the top of $2.74 from the end of last October. And then the players started to book the profit pushing the price down to the $2.4 area. It’s wise and natural to save such an incredible gain. Continue reading "Copper's Consolidation Offers Buying Opportunity for Freeport-McMoRan"